Temodal (Temozolomide) Post Marketing Surveillance Protocol (Study P05557AM2)

NCT00723827 · clinicaltrials.gov ↗

COMPLETED

Status

682

Enrollment

INDUSTRY

Sponsor class

Conditions

Glioblastoma
Glioma
Astrocytoma

Interventions

DRUG: Temozolomide
RADIATION: Radiotherapy

Sponsor

Merck Sharp & Dohme LLC